Organovo Holdings (ONVO) 7.08 $ONVO
Organovo Holdings, Inc.'s Presentations Now Available for On-Demand viewing at RetailInvestorConferences.com
CNW Group - Mon Sep 15, 7:00AM CDT
Company invites individual and institutional investors to log-on to RetailInvestorConferences.com to view presentations
Research and Markets: Global 3D Bioprinting Market 2014-2018: 3D Systems, EnvisionTEC, Organovo Holdings & Stratasys Dominate the Industry
Business Wire - Mon Sep 15, 6:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/sf36dc/global_3d) has announced the addition of the "Global 3D Bioprinting Market 2014-2018" report to their offering.
Global 3D Bioprinting Market 2014-2018: 3D Systems, EnvisionTEC, Organovo Holdings & Stratasys Dominate the Industry
M2 - Mon Sep 15, 5:58AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9qq57b/global_3d) has announced the addition of the "Global 3D Bioprinting Market 2014-2018" report to their offering. The Global 3D Bioprinting market to grow at a CAGR of 14.52% over the period 2013-2018 3D bioprinting is a process to produce tissues in a variety of formats from micro-scale tissues to standard multi-well tissues, where cell function and viability are preserved within the printed construct. A 3D bioprinter is a medical device used to regenerate human tissues, which are created by human cells. The 3D micro-engineered environments open new channels for drug screening and fundamental studies of wound healing, angiogenesis, and stem-cell niches. Many industries have already benefitted from multiple advancements in this field, resulting in improved and more efficient processes worldwide. The Global 3D Bioprinting market shows immense potential to grow rapidly in the future, mainly because of the advances in technology of the product. Technological advancements and innovations in the Healthcare industry have resulted in the development of equipment with up-to-date technology that is customized to the needs of patients. According to the report, growing demand from the drug discovery process is one of the major drivers in the market. The use of 3D bioprinting reduces the risk of drug failure during pre-clinical trial testing and minimizes the complications related to human trials. Further, the report states that one of the major challenges in the market is the high price of 3D bioprinting surgeries. The high cost of 3D printing lowers its acceptance among end-users. In addition, there is no healthcare support for 3D printing surgery, which makes it very difficult for many patients to opt for it. The Global 3D Bioprinting market can be segmented into the technology available in the market: - Ink-jet Bioprinters - Valve-based Cell Printers - Laser-assisted Cell Printers - Magnetic Levitation Bioprinters. Key Vendors - 3D Systems - EnvisionTEC - Organovo Holdings - Stratasys Prominent Vendors - 3D Biotek - Advanced Biomatrix - Bespoke Innovations - Digilab - regenHU - Nano3D Biosciences Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Technology - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/9qq57b/global_3d
Critical Alerts For FuelCell Energy, Receptos Inc., HD Supply Holdings Inc., Westport Innovations and Organovo Released By InvestorsObserver
PR Newswire - Thu Sep 11, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for FCEL, RCPT, HDS, WPRT and ONVO.
Organovo Holdings, Inc. to Webcast, Live, at RetailInvestorConferences.com September 11
PR Newswire - Tue Sep 09, 9:06AM CDT
Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual RetailInvestorConferences.com
Organovo to Present at the Morgan Stanley Global Healthcare Conference
PR Newswire - Fri Sep 05, 7:05AM CDT
Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"
, a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, has been invited to present at the Morgan Stanley Global Healthcare Conference, which will be held in New York September 8-10, 2014.
NASDAQ, NYSE, TSX, and OTC-listed Companies Webcast Live to Investors: September 11 at RetailInvestorConferences.com
CNW Group - Fri Sep 05, 7:00AM CDT
CEOs and top executives to take questions in real-time during formal roadshow presentations as well as meet and "chat" in virtual trade booths
Organovo Named 2015 Technology Pioneer by World Economic Forum
PR Newswire - Tue Aug 26, 2:30AM CDT
Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo" , a three-dimensional biology company focused on delivering pioneering 3D bioprinting technology, announced today that it has been recognized as a 2015 Technology Pioneer by the World Economic Forum (WEF). Organovo is one of 24 companies honored for the ability to harness creativity to design and create transformative solutions.
Global 3D Printing Market (Technology, Material, Services, Application and Geography) - Forecast to 2020
M2 - Tue Aug 19, 5:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d2nj3j/global_3d) has announced the addition of the "Global 3D Printing Market (Technology, Material, Services, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering. According to the report titled "3D Printing Market (Technologies, Materials, Applications and Geography) - Global Opportunity Analysis and Forecast-2013-2020", the global 3D printing market will reach $8.6 billion by 2020, registering a CAGR of 20.6% from 2014 to 2020. The surge in growth is primarily due to rising demand for faster and more efficient ways to manufacture complex design objects using a wide array of materials. The adoption of 3D printing in various applications is growing on account of higher accuracy, efficient use of material and ability to build customized products. Its competency over traditional processes, time efficiency and simultaneous use of multiple materials has been the other prominent adoption drivers. However, higher cost of personal printing, expensive software, and lack of channel partner assistance has been restraining the growth of the market. The economies of scale gained through advancement in technology and improved manufacturing process will help the market grow in future. Stereolithography, selective laser sintering, electron beam melting, fused deposition modeling, and laminated object manufacturing are some of the technologies currently being used for 3D printing. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 MARKET OVERVIEW CHAPTER 4 GLOBAL 3D PRINTING MARKET BY TECHNOLOGY CHAPTER 5 GLOBAL 3D PRINTING MARKET BY MATERIAL CHAPTER 6 GLOBAL 3D PRINTING MARKET BY APPLICATION CHAPTER 7 GLOBAL 3D PRINTING SERVICE MARKET CHAPTER 8 GLOBAL 3D PRINTING MARKET BY GEOGRAPHY CHAPTER 9 COMPANY PROFILES Companies Mentioned: - 3D Systems - Arcam AB - Autodesk - ExOne - Hoganas AB - Optomec - Organovo Holdings - Ponoko - Stratasys - Voxeljet Ag For more information visit http://www.researchandmarkets.com/research/d2nj3j/global_3d
Critical Alerts For Apple, Organovo, Boeing, Sears Holdings and Waters Released By InvestorsObserver
PR Newswire - Mon Aug 18, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for AAPL, ONVO, BA, SHLD and WAT.
3D Printing Companies for Your Stock Portfolio
at The Street - Wed Aug 13, 9:01AM CDT
Here are nine 3D Printing stocks and companies that you can invest in.
3 Stocks Under $10 to Trade for Breakouts
at The Street - Wed Aug 13, 6:00AM CDT
These under-$10 stocks are within range of triggering breakout trades.
Organovo Highlights Liver Toxicology Achievement, Reports Q1 Fiscal 2015 Results
PR Newswire - Tue Aug 12, 7:05AM CDT
Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo" , a three-dimensional biology company focused on delivering pioneering 3D bioprinting technology, has reported its first quarter, fiscal 2015, results and provided highlights of its recent activities.
Organovo Announces Appointment of Gregory T. Lucier as Corporate Advisor
PR Newswire - Wed Aug 06, 7:05AM CDT
Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo" , a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, announced today that Gregory T. Lucier has been appointed as a corporate advisor. In the role, Mr. Lucier will advise Chief Executive Officer Keith Murphy and the executive management team on various corporate issues.
4 Stocks Under $10 Moving Higher
at The Street - Wed Aug 06, 7:01AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Critical Alerts For Organovo, Regeneron Pharmaceuticals, CBS, Wynn Resorts and Sanofi Released By InvestorsObserver
PR Newswire - Fri Jul 25, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ONVO, REGN, CBS, WYNN, and SNY.
Why Organovo Holdings Inc Stock Bulked Up Today
Dan Carroll, The Motley Fool - Motley Fool - Thu Jul 24, 1:10PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Organovo , an innovative biotech company...
Organovo Holdings, Inc.'s Presentations Now Available for On-Demand viewing at RetailInvestorConferences.com
CNW Group - Mon Sep 15, 7:00AM CDT
Company invites individual and institutional investors to log-on to RetailInvestorConferences.com to view presentations
Research and Markets: Global 3D Bioprinting Market 2014-2018: 3D Systems, EnvisionTEC, Organovo Holdings & Stratasys Dominate the Industry
Business Wire - Mon Sep 15, 6:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/sf36dc/global_3d) has announced the addition of the "Global 3D Bioprinting Market 2014-2018" report to their offering.
Global 3D Bioprinting Market 2014-2018: 3D Systems, EnvisionTEC, Organovo Holdings & Stratasys Dominate the Industry
M2 - Mon Sep 15, 5:58AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9qq57b/global_3d) has announced the addition of the "Global 3D Bioprinting Market 2014-2018" report to their offering. The Global 3D Bioprinting market to grow at a CAGR of 14.52% over the period 2013-2018 3D bioprinting is a process to produce tissues in a variety of formats from micro-scale tissues to standard multi-well tissues, where cell function and viability are preserved within the printed construct. A 3D bioprinter is a medical device used to regenerate human tissues, which are created by human cells. The 3D micro-engineered environments open new channels for drug screening and fundamental studies of wound healing, angiogenesis, and stem-cell niches. Many industries have already benefitted from multiple advancements in this field, resulting in improved and more efficient processes worldwide. The Global 3D Bioprinting market shows immense potential to grow rapidly in the future, mainly because of the advances in technology of the product. Technological advancements and innovations in the Healthcare industry have resulted in the development of equipment with up-to-date technology that is customized to the needs of patients. According to the report, growing demand from the drug discovery process is one of the major drivers in the market. The use of 3D bioprinting reduces the risk of drug failure during pre-clinical trial testing and minimizes the complications related to human trials. Further, the report states that one of the major challenges in the market is the high price of 3D bioprinting surgeries. The high cost of 3D printing lowers its acceptance among end-users. In addition, there is no healthcare support for 3D printing surgery, which makes it very difficult for many patients to opt for it. The Global 3D Bioprinting market can be segmented into the technology available in the market: - Ink-jet Bioprinters - Valve-based Cell Printers - Laser-assisted Cell Printers - Magnetic Levitation Bioprinters. Key Vendors - 3D Systems - EnvisionTEC - Organovo Holdings - Stratasys Prominent Vendors - 3D Biotek - Advanced Biomatrix - Bespoke Innovations - Digilab - regenHU - Nano3D Biosciences Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Technology - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/9qq57b/global_3d
Critical Alerts For FuelCell Energy, Receptos Inc., HD Supply Holdings Inc., Westport Innovations and Organovo Released By InvestorsObserver
PR Newswire - Thu Sep 11, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for FCEL, RCPT, HDS, WPRT and ONVO.
Organovo Holdings, Inc. to Webcast, Live, at RetailInvestorConferences.com September 11
PR Newswire - Tue Sep 09, 9:06AM CDT
Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual RetailInvestorConferences.com
Organovo to Present at the Morgan Stanley Global Healthcare Conference
PR Newswire - Fri Sep 05, 7:05AM CDT
Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"
, a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, has been invited to present at the Morgan Stanley Global Healthcare Conference, which will be held in New York September 8-10, 2014. NASDAQ, NYSE, TSX, and OTC-listed Companies Webcast Live to Investors: September 11 at RetailInvestorConferences.com
CNW Group - Fri Sep 05, 7:00AM CDT
CEOs and top executives to take questions in real-time during formal roadshow presentations as well as meet and "chat" in virtual trade booths
Organovo Named 2015 Technology Pioneer by World Economic Forum
PR Newswire - Tue Aug 26, 2:30AM CDT
Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"
, a three-dimensional biology company focused on delivering pioneering 3D bioprinting technology, announced today that it has been recognized as a 2015 Technology Pioneer by the World Economic Forum (WEF). Organovo is one of 24 companies honored for the ability to harness creativity to design and create transformative solutions. Global 3D Printing Market (Technology, Material, Services, Application and Geography) - Forecast to 2020
M2 - Tue Aug 19, 5:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d2nj3j/global_3d) has announced the addition of the "Global 3D Printing Market (Technology, Material, Services, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering. According to the report titled "3D Printing Market (Technologies, Materials, Applications and Geography) - Global Opportunity Analysis and Forecast-2013-2020", the global 3D printing market will reach $8.6 billion by 2020, registering a CAGR of 20.6% from 2014 to 2020. The surge in growth is primarily due to rising demand for faster and more efficient ways to manufacture complex design objects using a wide array of materials. The adoption of 3D printing in various applications is growing on account of higher accuracy, efficient use of material and ability to build customized products. Its competency over traditional processes, time efficiency and simultaneous use of multiple materials has been the other prominent adoption drivers. However, higher cost of personal printing, expensive software, and lack of channel partner assistance has been restraining the growth of the market. The economies of scale gained through advancement in technology and improved manufacturing process will help the market grow in future. Stereolithography, selective laser sintering, electron beam melting, fused deposition modeling, and laminated object manufacturing are some of the technologies currently being used for 3D printing. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 MARKET OVERVIEW CHAPTER 4 GLOBAL 3D PRINTING MARKET BY TECHNOLOGY CHAPTER 5 GLOBAL 3D PRINTING MARKET BY MATERIAL CHAPTER 6 GLOBAL 3D PRINTING MARKET BY APPLICATION CHAPTER 7 GLOBAL 3D PRINTING SERVICE MARKET CHAPTER 8 GLOBAL 3D PRINTING MARKET BY GEOGRAPHY CHAPTER 9 COMPANY PROFILES Companies Mentioned: - 3D Systems - Arcam AB - Autodesk - ExOne - Hoganas AB - Optomec - Organovo Holdings - Ponoko - Stratasys - Voxeljet Ag For more information visit http://www.researchandmarkets.com/research/d2nj3j/global_3d
Critical Alerts For Apple, Organovo, Boeing, Sears Holdings and Waters Released By InvestorsObserver
PR Newswire - Mon Aug 18, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for AAPL, ONVO, BA, SHLD and WAT.
3D Printing Companies for Your Stock Portfolio
at The Street - Wed Aug 13, 9:01AM CDT
Here are nine 3D Printing stocks and companies that you can invest in.
3 Stocks Under $10 to Trade for Breakouts
at The Street - Wed Aug 13, 6:00AM CDT
These under-$10 stocks are within range of triggering breakout trades.
Organovo Highlights Liver Toxicology Achievement, Reports Q1 Fiscal 2015 Results
PR Newswire - Tue Aug 12, 7:05AM CDT
Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"
, a three-dimensional biology company focused on delivering pioneering 3D bioprinting technology, has reported its first quarter, fiscal 2015, results and provided highlights of its recent activities. Organovo Announces Appointment of Gregory T. Lucier as Corporate Advisor
PR Newswire - Wed Aug 06, 7:05AM CDT
Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"
, a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, announced today that Gregory T. Lucier has been appointed as a corporate advisor. In the role, Mr. Lucier will advise Chief Executive Officer Keith Murphy and the executive management team on various corporate issues. 4 Stocks Under $10 Moving Higher
at The Street - Wed Aug 06, 7:01AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Critical Alerts For Organovo, Regeneron Pharmaceuticals, CBS, Wynn Resorts and Sanofi Released By InvestorsObserver
PR Newswire - Fri Jul 25, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ONVO, REGN, CBS, WYNN, and SNY.
Why Organovo Holdings Inc Stock Bulked Up Today
Dan Carroll, The Motley Fool - Motley Fool - Thu Jul 24, 1:10PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Organovo , an innovative biotech company...
